메뉴 건너뛰기




Volumn 70, Issue 8, 2003, Pages 702-704

Q: Is there a role for metformin or acarbose as a weight-loss agent in the absence of diabetes?

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; CARBOHYDRATE; GLUCOSE; INSULIN; METFORMIN; PLACEBO; SULFONYLUREA; ANTIDIABETIC AGENT;

EID: 0042976521     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.8.702     Document Type: Article
Times cited : (7)

References (7)
  • 1
    • 0031614038 scopus 로고    scopus 로고
    • Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
    • Lee A, Morley JE. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 1998; 6:47-53.
    • (1998) Obes. Res. , vol.6 , pp. 47-53
    • Lee, A.1    Morley, J.E.2
  • 2
    • 9544247850 scopus 로고    scopus 로고
    • The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution (BIGPRO trial)
    • Fontbonne A, Charles MA, Juhan-Vague I, et al. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution (BIGPRO trial). Diabetes Care 1996; 19:920-926.
    • (1996) Diabetes Care , vol.19 , pp. 920-926
    • Fontbonne, A.1    Charles, M.A.2    Juhan-Vague, I.3
  • 3
    • 0034914193 scopus 로고    scopus 로고
    • Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30
    • Glueck CJ, Fontaine RN, Wang P, et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism 2001; 50:856-861.
    • (2001) Metabolism , vol.50 , pp. 856-861
    • Glueck, C.J.1    Fontaine, R.N.2    Wang, P.3
  • 4
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Diabetes Prevention Program Research Group
    • Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
    • (2002) N. Engl. J. Med. , vol.346 , pp. 393-403
  • 5
    • 0031883091 scopus 로고    scopus 로고
    • Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycemic effect
    • Ranganath L, Norris F, Morgan L, Wright J, Marks V. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycemic effect. Diabetes Med 1998; 15:120-124.
    • (1998) Diabetes Med. , vol.15 , pp. 120-124
    • Ranganath, L.1    Norris, F.2    Morgan, L.3    Wright, J.4    Marks, V.5
  • 7
    • 0035663752 scopus 로고    scopus 로고
    • Effect of acarbose on weight maintenance after dietary weight loss in obese subjects
    • Hauner H, Petzinna D, Sommerauer B, Toplak H. Effect of acarbose on weight maintenance after dietary weight loss in obese subjects. Diabetes Obes Metab 2001; 3:423-427.
    • (2001) Diabetes Obes. Metab. , vol.3 , pp. 423-427
    • Hauner, H.1    Petzinna, D.2    Sommerauer, B.3    Toplak, H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.